Second, we did not determine the 24-h Holter and more complex cardiac electroactivity parameters such as heart rate variability, PR and QT interval variability in this report, further calculation should be performed in the future to evaluate relevant arrhythmias and the sympathetic and parasympathetic effect of the FGF21. The gene discussed is FGF21; the disease is Arrhythmia.